维普中文期刊产品整合服务
284篇 您的检索式:作者名="Mosekilde L"
    题名 作者 年代 出处 被引量
1Age-related changes in bone mass,structure,andstrength-effects of loading显示文摘Mosekilde L 2000Z Rheumatol2000,59,1:1
2Postsurgical hypoparathyroidism-risk of fractures,psychiatric diseases,cancer,cataract,and infections显示文摘Underbjerg L Sikjaer T Mosekilde L 2014J Bone Miner Res2014,29,11:1
3Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk 显示文摘Vestergaard P Rejnmark L Mosekilde L 2005Diabetologia2005,48,7:1
4Hyperthyroidism, bone mineral and fracture risk-a meta-analysis 显示文摘Vestergaard P Mosekilde L 2003Thyroid2003,13,6:1
5Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers显示文摘Hauge EM Qvesel D Eriksen EF Mosekilde L Melsen F 0,,:1
6Effects of thyroid hormones on bone and mineral metabolism 显示文摘Mosekilde L Eriksen EF Charles P 1990Endocrinol Metab Clin North Am1990,19,1:1
7Reduced fracture risk in users of thiazide diuretics显示文摘Rejnmark L Vestergaard P Mosekilde L 2005Calcif Tissue Int2005,76,3:1
8Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients 显示文摘Vestergaard P Mosekilde L 2002Thyroid2002,12,5:1
9The effects of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats显示文摘Mosekilde L Danielsen CC 1993Bone1993,14,1:1
10Emerging anabolic treatments in osteoporosis显示文摘Mosekilde L Torring O Rejnmark L 2011Current Drug Safety2011,6,2:1
11Influence of hyperand hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk显示文摘Vestergaard P Rejnmark L Mosekilde L 2005Calcif Tissue Int2005,77,3:1
12Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats显示文摘Toromanoff A Ammann P Mosekilde L 1997Endocrinology1997,138,:1
13Increased mor- tality in patients with a hip fracture-effect of pre-morbid and postfracture complications 显示文摘Vestergaard P Rejnmark L Mosekilde L 2007Osteoporos Int2007,18,:1
14Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture 显示文摘Vestergaard P Rejnmark L Mosekilde L 2006Calcif Tissue Int2006,79,2:1
15Reduced concentration of collagen reducible cross links in human trabecullar bone with respect to age and osteoporosis 显示文摘Oxlund H Mosekilde L Ortoft G 1996Bone1996,19,5:1
16Sex differences in age - related loss of verte - bral trabecular bone mass and structure: biomechanical consequences显示文摘Mosekilde L 1989Bone1989,10,:1
17Fracture risk associated with systemic and topical corticosteroids显示文摘VESTERGAARD P REINMARK L MOSEKILDE L 2005In- tern Med2005,257,4:1
18Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism 显示文摘lASTRUP B MOSEKILDE L MELSEN F 1982Metabolism1982,31,2:1
19Emerging anabolic treatments in osteoporosis 显示文摘Mosekilde L Tsrring O Rejnmark L 2011CurrDrug Safety2011,6,2:1
20Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals显示文摘Mosekilde L Danielsen CC 1987Bone1987,,8:1
返回顶部 每页显示:
共15页 首页 上一页 第1页 下一页 末页 /15 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费